KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and ...

Several intravenous and subcutaneous Ig (SCIg) preparations are available either ... approved maximum infusion rate and excipients. [51–53] All these factors may contribute to treatment efficacy ...

About the Insignis Infusion System The Insignis Syringe Infusion ... effective for patients requiring subcutaneous immunoglobulin (SCIg) for Primary or Secondary Immune Deficiency and ...

The ability to infuse a larger infusion volume is expected to increase ... as compared to weekly or bi-weekly with conventional SCIG treatments. “We are delighted that HYQVIA, approved in ...